Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study.

Sundaram SubramanianRammohan PrasannaGhanashyam BiswasSaroj Kumar Das MajumdarNisarg JoshiDeepak BungerMujtaba A Khan Imran Ahmad

Published in: Breast cancer (Dove Medical Press) (2020)

Nanosomal docetaxel lipid suspension-based chemotherapy was efficacious and well tolerated in the treatment of breast cancer. Further, NDLS is being evaluated prospectively in patients with triple-negative breast cancer (ClinicalTrials.gov: NCT03671044).

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
fatty acid
radiation therapy
clinical trial
combination therapy
young adults
replacement therapy
smoking cessation
childhood cancer